What Is KLOW Peptide? Four Parts, One Vial
KLOW is four separate parts in one vial
Research teams first made the KLOW parts for separate needs. Sellers later put all four in one vial. The parts don't form a new substance. What is KLOW peptide? It's this four-part lab mix.
A usual vial holds 80 mg in all. GHK-Cu supplies 50 mg. BPC-157 supplies 10 mg. TB-500 supplies 10 mg. KPV supplies 10 mg. Water spreads them through one liquid. It doesn't join them.
KPV work asked about a sore gut. GHK-Cu raised collagen in treated skin. GHK-Cu makes up 62.5% of the vial. Most BPC-157 repair work used rodents. One small human test only checked safety. TB-500 copies a small section of thymosin beta-4. That larger body-made protein has wound and heart research. The FDA hasn't approved this four-part use.
No fair test has covered the complete blend. No test compared KLOW with a smaller mix. None used a placebo, which looks like care but has no active drug. Claims that the four parts team up remain guesses.
The klow stack page compares their blood times.
Your body still handles four separate substances. Your response remains unknown.
Your body still receives four parts. You can’t know how they act together.
What is KLOW peptide made from?
KPV: KPV copies three linked parts of a body hormone. That hormone guides skin color and swelling. Gut cells took in KPV during lab work. Sore tissue took in more. Each liter held about 160 micromoles of KPV. Chemists use micromoles to count very small amounts. Here, it only tells what touched the cells. One immune alarm had the lab name IL-6. That label won’t guide your care. Mice with colitis improved after drinking KPV [3]. Colitis means a sore and swollen colon.
GHK-Cu: this peptide holds copper. In 1973, Loren Pickart found GHK in a human blood sample [4]. Blood levels tend to fall with age. Treated skin made more collagen. In a dish, GHK-Cu changed how cells used DNA directions by 50% or more [5]. The changes involved repair and cell defense. They didn't prove safer use or better skin. Copper gives GHK-Cu its blue color.
BPC-157: the full name is Body Protection Compound 157. Its fifteen amino acids form its protein chain. Scientists copied it from a stomach protein. It helped a cut rat Achilles tendon heal in 2003 [2]. In animals, half left blood in about 30 minutes [8].
TB-500: thymosin beta-4 is a larger protein made by your body. TB-500 copies just a small part of that protein. A lab lists the short copy at about 889 daltons. Chemists use daltons to tell tiny molecules apart. The weight doesn't show healing or blood time. Most wound and heart results came from full thymosin beta-4. The world sports drug authority bans TB-500 and thymosin beta-4 at all times [7][10].
Each part has its own record. The mix still has none.
Your care can’t rest on dish work. You need human results.
The 80 mg vial can't keep all four parts level
One dry vial holds 80 mg. Its split is 50/10/10/10. GHK-Cu makes up about 62.5% of the weight. Each other part supplies 10 mg.
The mix rests on a simple idea. KPV may lower swelling. Tissue may hold its shape better after GHK-Cu. BPC-157 may affect tendons, the gut, and blood vessels. Sellers link TB-500 to wound cover. Those jobs might fit together. Researchers haven't tested that claim.
The papers list lab weights from 342 daltons to 1419 daltons. Chemists use daltons to tell tiny molecules apart. These weights don't show how long each part stays. Blood also clears the parts at different speeds. Half the BPC-157 left in about 30 minutes [8]. The two smallest parts may leave sooner [9].
One vial can't hold all four levels steady. The klow stack page compares the known blood times.
Your blood may never line up all four effects.
KLOW isn't a weight drug or an approved medicine
KLOW isn't a GLP-1 drug, the group doctors use for weight care. It isn't an approved weight-loss drug or a proved weight aid. No part carries that accepted use. Some websites call it a weight blend. The research doesn't support that claim.
KLOW isn't GLOW. GLOW has GHK-Cu, BPC-157, and TB-500. KLOW adds KPV as a fourth part. KPV is the part studied for gut swelling.
KLOW isn't WOLVERINE. That name belongs to another blend.
The FDA hasn't approved KLOW. No part has approval for this four-part use. FDA's page, current as of April 22, 2026, says the BPC-157 nominations were withdrawn and it is no longer in Category 2; FDA has not answered what a compounding pharmacy may do with that. That isn't an approval or a safety score. It flags serious concerns when pharmacies make drugs to order. World sport rules ban TB-500 and the larger thymosin beta-4 protein at all times [7][10].
The KLOW research page explains each result.
Take these limits to your doctor. A weight claim can't predict what KLOW does in you.